Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses

Rhea-AI Summary

Meridian Bioscience announced the launch of its Lyo-Ready™ RT-LAMP Mix, aimed at enhancing RNA virus detection. This product facilitates development of assays that can be stored at ambient temperatures, eliminating the need for cold storage. The RT-LAMP technology simplifies point-of-care testing, reducing costs and complexity. The newly formulated mix offers superior amplification sensitivity and specificity, catering to various applications, including human diagnostics and environmental testing. With COVID-19 testing needs, this innovation positions Meridian to meet market demands effectively.

Positive

• Launch of Lyo-Ready™ RT-LAMP Mix enhances RNA virus detection capabilities.
• Enables ambient temperature storage, eliminating cold chain logistics.
• Designed for rapid and sensitive testing, reducing development time.
• Technology applicable in diverse fields: human, veterinary, environmental.

Negative

• None.

CINCINNATI, June 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-Ready™ RT-LAMP Mix, specifically designed for accelerating the development of ambient temperature stable reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assays. The Lyo-Ready™ RT-LAMP Mix is formulated for rapid, robust, and sensitive detection of RNA viruses.

RT-LAMP technology is perfectly suited for point-of-care or portable testing because assays are performed at one single temperature, which reduces the cost and complexity of the device without the requirement of a thermocycler. RT-LAMP has been successfully used in the diagnosis of infectious diseases caused by RNA viruses, such as influenza, hepatitis C, West Nile fever, Dengue virus and Ebola virus. The accuracy and relatively simple equipment requirement makes RT-LAMP the perfect technology for use as a practical solution for point-of-care detection of viruses, particularly in non-standard institutions such as airports, rural hospitals or in the home. Applications for this technology go beyond human diagnostics expanding to veterinary, environmental, AgBio, and food testing.

However, in order to have this wide reach, RT-LAMP diagnostic developers need to eliminate the need for cold storage of the assay.   To facilitate development of tests that can be stored at ambient temperature, Meridian has designed the new Lyo-Ready™ RT-LAMP 1-Step Mix as a glycerol-free, and uniquely high 4x concentration format mix, containing pre-optimized lyo-excipients. Its unique formulation expedites the assay optimization, reducing development time of room temperature stable RT-LAMP assays with superior amplification sensitivity and specificity.

Florent Chang-Pi-Hin, Ph.D., Vice President of Research & Development – Life Science, commented, “Our new Lyo-Ready RT-LAMP mix contains all enzymes required for RNA detection with reverse transcriptase and Bst Polymerase in a lyophilization compatible format. With the pressing needs of COVID-19 testing, lyophilization opens the door to a faster and near patient alternative to the diagnosis. We are delighted to announce the release of our new Lyo-Ready™ LAMP 1-Step Mix, which outperforms the competition with market leading sensitivity and specificity while also enabling point-of-care with ambient temperature storage capability.”

Meridian is committed to providing innovative solutions to diagnostic manufacturers that simplify and accelerate the development of superior diagnostic assays. For more information about partnering with Meridian Bioscience, please visit https://meridianlifescience.com/lamp or contact Dr. Chang-Pi-Hin at florent.chang-pi-hin@meridianlifescience.com.        

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

What is the Lyo-Ready™ RT-LAMP Mix launched by Meridian Bioscience?

The Lyo-Ready™ RT-LAMP Mix is a diagnostic tool for the sensitive detection of RNA viruses, designed for ambient temperature storage without cold chain logistics.

How does RT-LAMP technology benefit point-of-care testing?

RT-LAMP technology allows testing at a single temperature, reducing equipment costs and complexity, making it suitable for decentralized testing locations.

What are the applications of the Lyo-Ready™ RT-LAMP Mix?

The mix is applicable in human diagnostics, veterinary testing, environmental assessments, and food testing.

How does Meridian's new mix improve RNA virus detection?

It offers superior amplification sensitivity and specificity compared to existing solutions, facilitating quicker and more accurate results.

When was the Lyo-Ready™ RT-LAMP Mix announced?

The Lyo-Ready™ RT-LAMP Mix was announced on June 16, 2021.

What is the stock symbol for Meridian Bioscience?

Meridian Bioscience is traded under the stock symbol VIVO.